Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase II Immunotherapy Trial of Inoperable Pancreatic Cancer

NCT03165591 is registered in ClinicalTrials.gov with Immunitor LLC as lead sponsor.

NCT NCT03165591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase II Immunotherapy Trial of Inoperable Pancreatic Cancer
Lead sponsor
Immunitor LLC
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 1, 2017
Completion date
December 31, 2020
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer non-resectable